Oral cancer is not among the most common cancers, but it is far from rare. In the United States, an estimated 60,480 new cases of oral cavity and throat cancer will be diagnosed in 2026, with about 13,150 deaths. That translates to roughly 11.5 new cases per 100,000 adults each year. To put that in perspective, oral cancer is more common than cervical cancer, stomach cancer, or melanoma of the skin in some populations, and its numbers have been climbing in recent decades.
How Common It Is Compared to Other Cancers
Oral and throat cancers account for roughly 3% of all cancers diagnosed in the U.S. each year. That places them in the middle tier: not as prevalent as breast, lung, or colon cancer, but frequent enough that tens of thousands of people receive this diagnosis annually. The rate has been rising, largely because of an increase in cancers linked to HPV (human papillomavirus) in the back of the throat, especially among men.
Who Gets Oral Cancer
Men develop oral cancer at roughly twice the rate women do. This gap is partly explained by higher rates of tobacco and alcohol use and by the sharp rise in HPV-related throat cancers, which disproportionately affect men. Most people are diagnosed after age 50, though HPV-driven cases are shifting the age of diagnosis somewhat younger than in previous decades.
Race also plays a role. Black men historically have had higher incidence and mortality rates than white men, though those differences have narrowed over time as smoking rates have declined broadly.
The Biggest Risk Factors
Tobacco is the single strongest risk factor. About 80% of people diagnosed with oral cancer have a history of smoking or other tobacco use, including chewing tobacco and snuff. Alcohol is the second major driver, and the two together multiply the danger: people who both smoke heavily and drink heavily face roughly 30 times the risk of someone who does neither.
HPV has become the other major cause, particularly for cancers in the oropharynx (the base of the tongue and tonsils). The CDC estimates that about 70% of oropharyngeal cancers are caused by HPV, totaling around 16,000 cases per year in the U.S. This makes oropharyngeal cancer the most common HPV-related cancer in men. HPV vaccination, now recommended for preteens and available through age 45, is expected to reduce these numbers over the coming decades.
Other risk factors include prolonged sun exposure (for lip cancer), a diet low in fruits and vegetables, betel nut chewing (common in parts of South and Southeast Asia), and a weakened immune system.
Early Warning Signs
Oral cancer often starts as something easy to dismiss: a sore that doesn’t heal, a white or reddish patch on the inside of the mouth, or a small lump. The key distinguishing factor is persistence. Common canker sores typically resolve within one to two weeks. A sore or patch that lingers beyond two weeks deserves a professional evaluation.
Other signs include:
- Loose teeth with no obvious dental explanation
- A growth or lump inside the mouth or on the lip
- Persistent mouth or ear pain
- Difficulty or pain when swallowing
Many of these symptoms overlap with harmless conditions, which is why they’re frequently ignored. The two-week rule is a practical threshold: if something in your mouth looks or feels abnormal and hasn’t improved in that time, get it checked.
How It’s Detected
The American Dental Association recommends that dentists perform a visual and tactile examination of the mouth, lips, and surrounding areas during routine visits for all adult patients. This involves looking at and feeling the soft tissues for anything unusual. If a suspicious lesion is found, the next step is a biopsy, either performed on the spot or through a referral to a specialist. There is no widely recommended self-screening tool or at-home test, which makes regular dental visits one of the most practical forms of early detection.
Survival Rates by Location and Stage
Oral cancer survival depends heavily on where the cancer is and how early it’s caught. The five-year survival rates, based on U.S. data from 2015 to 2021, vary significantly:
For cancer of the tongue, the five-year survival rate is 88% when the cancer is still localized (confined to the original site), 70% when it has spread to nearby lymph nodes, and 39% when it has reached distant parts of the body. Floor-of-mouth cancers have lower survival across all stages: 72% localized, 43% regional, and 22% distant. Lip cancers tend to have better outcomes, with a 95% survival rate when caught early.
Oropharyngeal cancers (back of the throat) show a somewhat different pattern. Localized cases have an 86% five-year survival rate, and regional cases still do relatively well at 79%. This is partly because many of these are HPV-positive tumors, which tend to respond better to treatment than HPV-negative cancers. Current survival statistics don’t yet separate HPV-positive from HPV-negative cases, so these numbers likely understate the prognosis for HPV-driven cancers and overstate it for others.
Why Early Detection Matters So Much
The gap between early-stage and late-stage survival is dramatic for oral cancer. A floor-of-mouth cancer caught while still localized has more than three times the survival rate of one that has spread distantly. Yet many oral cancers are not found until they’ve already grown or spread, partly because early-stage disease is painless and partly because people skip or delay dental visits. Keeping up with routine dental exams and paying attention to changes in your mouth that last more than two weeks are the most effective things you can do to catch this cancer when it’s most treatable.